These compounds have not been evaluated or approved by Health Canada for human use.
Apoptosis and Cellular Surveillance Apoptosis is the natural, programmed death of cells that are damaged or no longer needed
Cagrilintide Reconstitution Cagrilintide - dose per draw at common vial sizes Vial Size 5 mg BAC Water 2.0 mL Concentration 2.5 mg/mL 0.25 mg 0.10 mL (10 units) 0.5 mg 0.20 mL (20 units) 1.0 mg 0.40 mL (40 units) 2.4 mg 0.96 mL (96 units) Vial Size 10 mg BAC Water 2.0 mL Concentration 5.0 mg/mL 0.25 mg 0.05 mL (5 units) 0.5 mg 0.10 mL (10 units) 1.0 mg 0.20 mL (20 units) 2.4 mg 0.48 mL (48 units) Vial Size 10 mg BAC Water 1.0 mL Concentration 10.0 mg/mL 0.25 mg 0.025 mL (2.5 units) 0.5 mg 0.05 mL (5 units) 1.0 mg 0.10 mL (10 units) 2.4 mg 0.24 mL (24 units) Cagrilintide is sensitive - inject BAC water down the vial wall and swirl gently
Dosing Protocol A structured daily approach with gradual adjustments to support tolerance and effectiveness: Weeks 12 (Initiation): 600 mcg total per day (300 mcg of each peptide)
Thymosin Beta-4 is a 43-amino-acid peptide widely used in preclinical experimental systems to study actin-mediated cell migration, angiogenesis, inflammatory signaling, and tissue remodeling processes
Injecting both into the same subcutaneous depot on the same day reduces bioavailability for both compounds due to localized saturation and competing lymphatic uptake